[1] Dhanuthai K, Chantarangsu S, Rojanawatsirivej S, et al.Ameloblastoma: a multicentric study[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2012, 113(6): 782-788.
[2] Vered M, Wright JM.Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone Tumours[J]. Head Neck Pathology, 2022, 16(1): 63-75.
[3] Abtahi MA, Zandi A, Razmjoo H, et al.Orbital invasion of ameloblastoma: A systematic review apropos of a rare entity[J]. J Curr Ophthalmol, 2018, 30(1): 23-34.
[4] 贾雪萍,唐恩溢. 彻底刮治术治疗下颌骨成釉细胞瘤的临床研究[J]. 口腔医学研究,2017,33(5): 567-570.
[5] Hendra FN, van Cann EM, Helder MN, et al. Global incidence and profile of ameloblastoma: A systematic review and meta-analysis[J]. Oral Diseases, 2020, 26(1): 12-21.
[6] Fernandes D, Silveira HAD, Barbeiro CDO, et al.Peripheral desmoplastic ameloblastoma in the mandible[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2020, 129(1): e32.
[7] 李乐,刘亚男,张俊,等. 单囊型成釉细胞瘤根治性治疗和保守性治疗有效性及安全性的Meta分析[J].实用医学杂志,2021,37(20): 2614-2618.
[8] Hendra FN, Kalla DSN, van Cann EM, et al. Radical vs conservative treatment of intraosseous ameloblastoma: Systematic review and meta-analysis[J]. Oral Diseases, 2019, 25(7): 1683-1696.
[9] Heikinheimo K, Huhtala JM, Thiel A, et al.The Mutational Profile of Unicystic Ameloblastoma[J]. Journal of Dental Research, 2019, 98(1): 54-60.
[10] Au SW, Li KY, Choi WS, et al.Risk factors for recurrence of ameloblastoma: a long-term follow-up retrospective study[J]. International Journal of Oral and Maxillofacial Surgery, 2019, 48(10): 1300-1306.
[11] Yang R, Liu Z, Gokavarapu S, et al.Recurrence and cancerization of ameloblastoma: multivariate analysis of 87 recurrent craniofacial ameloblastoma to assess risk factors associated with early recurrence and secondary ameloblastic carcinoma[J]. Chin J Cancer Res, 2017, 29(3): 189-195.
[12] Neagu D, Escuder-de la Torre O, Vázquez-Mahía I, et al. Surgical management of ameloblastoma. Review of literature[J]. Journal of Clinical and Experimental Dentistry, 2019, 11(1): e70-e75.
[13] Tahmasebi E, Mohammadi M, Alam M, et al.The current regenerative medicine approaches of craniofacial diseases: A narrative review[J]. Front Cell Dev Biol, 2023, 11: 1112378.
[14] Chadwick JW, Huang SRC, Khadivi A, et al.Multidisciplinary management of an advanced mandibular ameloblastoma: Etiopathogenesis, surgical management and prosthetic rehabilitation[J]. Oral and Maxillofacial Surgery Cases, 2023, 9(2): 100296.
[15] 陆长玺, 郭传瑸. 成釉细胞瘤侵袭深度的初步测量研究[J]. 现代口腔医学杂志,2019,33(5):270-273.
[16] Goh YC, Siriwardena BSMS, Tilakaratne WM.Association of clinicopathological factors and treatment modalities in the recurrence of ameloblastoma: Analysis of 624 cases[J]. Journal of Oral Pathology Medicine, 2021, 50(9): 927-936.
[17] Das KN, Sharma V, Dixit PK, et al.The Colossal Mandibular Ameloblastoma: Surgical Challenges and Current Perspectives of Management[J]. Journal of Maxillofacial Oral Surgery, 2023, 22(4): 1166-1171.
[18] Adebayo ET, Fomete B, Adekeye EO.Delayed soft tissue recurrence after treatment of ameloblastoma in a black African: case report and review of the literature[J]. J Craniomaxillofac Surg, 2011, 39(8): 615-618. |
